Trending Stock News

As Bemis (BMS) Stock Price Declined, Starboard Value LP Decreased Its Stake; Johnson Financial Group Has Trimmed Biogen (BIIB) Holding as Stock Price Declined

Biogen Inc. (NASDAQ:BIIB) Logo

Jeffrey Smith decreased its stake in Bemis Inc (BMS) by 6.58% based on its latest 2018Q1 regulatory filing with the SEC. Starboard Value Lp sold 140,250 shares as the company’s stock declined 2.24% with the market. The hedge fund run by Jeffrey Smith held 1.99M shares of the consumer durables company at the end of 2018Q1, valued at $86.59M, down from 2.13M at the end of the previous reported quarter. Starboard Value Lp who had been investing in Bemis Inc for a number of months, seems to be less bullish one the $3.91 billion market cap company. The stock increased 0.56% or $0.24 during the last trading session, reaching $42.93. About 518,103 shares traded. Bemis Company, Inc. (NYSE:BMS) has declined 1.36% since June 15, 2017 and is downtrending. It has underperformed by 13.93% the S&P500. Some Historical BMS News: 23/04/2018 – S&P REVISES BEMIS CO. INC. TO RATING ‘BBB-‘ FROM ‘BBB’; 16/03/2018 – BEMIS-BOARD APPOINTED GUILLERMO NOVO, MARRAN H. OGILVIE, GEORGE W. WURTZ lll, AND ROBERT H. YANKER AS NEW INDEPENDENT DIRECTORS EFFECTIVE IMMEDIATELY; 26/04/2018 – BEMIS COMPANY INC – QTRLY ADJ SHR $0.63; 16/03/2018 – Bemis Names Guillermo Novo, Marran H. Ogilvie to Board; 26/04/2018 – BEMIS COMPANY INC – MANAGEMENT MAINTAINED FULL YEAR 2018 CASH FROM OPERATIONS GUIDANCE IN THE RANGE OF $420 TO $450 MILLION; 12/04/2018 – Bemis Presenting at Wells Fargo Industrials Conference May 8; 29/05/2018 – Bemis Closes Below 50-Day Moving Average: Technicals; 16/03/2018 – BEMIS COMPANY – FOLLOWING 2018 ANNUAL MEETING, BOARD WILL BE COMPRISED OF 13 DIRECTORS; 26/04/2018 – BEMIS COMPANY INC QTRLY NET SALES $1,027.4 MLN VS $995.4 MLN; 16/03/2018 – Bemis: Board to Be Comprised of 13 Directors After Annual Meeting

Johnson Financial Group Inc decreased its stake in Biogen Inc (BIIB) by 83.37% based on its latest 2018Q1 regulatory filing with the SEC. Johnson Financial Group Inc sold 1,534 shares as the company’s stock declined 1.31% with the market. The institutional investor held 306 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $84,000, down from 1,840 at the end of the previous reported quarter. Johnson Financial Group Inc who had been investing in Biogen Inc for a number of months, seems to be less bullish one the $64.50B market cap company. The stock decreased 0.40% or $1.23 during the last trading session, reaching $305.68. About 1.08 million shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 13.14% since June 15, 2017 and is uptrending. It has outperformed by 0.57% the S&P500. Some Historical BIIB News: 14/05/2018 – Primecap Adds Moody’s, Exits Constellium, Cuts Biogen: 13F; 05/04/2018 – BIOGEN – UNDER TERMS OF AGREEMENT, ABBVIE WILL GRANT PATENT LICENSES FOR USE AND SALE OF IMRALDI IN EUROPE, ON A COUNTRY-BY-COUNTRY BASIS; 17/04/2018 – T Rowe Price Growth Adds Disney, Exits Biogen, Cuts Apple; 17/04/2018 – Biogen Builds on Its 40-Year Legacy in Neuroscience with Presentation of Research from Its Portfolio of Medicines and Investigational Programs for Neurodegenerative Diseases; 20/04/2018 – $BIIB $IONS Interesting slide on antisense and gene therapy being “Complementary”, “Combination / sequential”. Will see if Biogen answer any question re $AVXS; 05/04/2018 – $ABBV $BIIB Settlement on Humira #Biosimilar in Europe -; 24/04/2018 – BIOGEN INC QTRLY NON-GAAP DILUTED EPS $6.05; 13/04/2018 – Biogen’s Tecfidera Weekly Retail Sales Rose 0.5%: Symphony; 05/04/2018 – BIOGEN: PRECISE TERMS OF PACT WITH ABBVIE ARE CONFIDENTIAL; 24/04/2018 – Biogen’s rain-making rare-disease drug hits a sales slump

Among 17 analysts covering Bemis Company Inc. (NYSE:BMS), 4 have Buy rating, 1 Sell and 12 Hold. Therefore 24% are positive. Bemis Company Inc. had 57 analyst reports since September 14, 2015 according to SRatingsIntel. RBC Capital Markets maintained the stock with “Sell” rating in Tuesday, May 30 report. BMO Capital Markets upgraded Bemis Company, Inc. (NYSE:BMS) on Friday, June 23 to “Outperform” rating. SunTrust initiated Bemis Company, Inc. (NYSE:BMS) on Wednesday, July 13 with “Buy” rating. RBC Capital Markets maintained Bemis Company, Inc. (NYSE:BMS) rating on Tuesday, September 5. RBC Capital Markets has “Sell” rating and $39.0 target. The firm earned “Underperform” rating on Friday, February 2 by Bank of America. On Monday, April 2 the stock rating was upgraded by Bank of America to “Buy”. The company was downgraded on Friday, March 18 by Vertical Research. The stock of Bemis Company, Inc. (NYSE:BMS) has “Sell” rating given on Monday, October 9 by RBC Capital Markets. Wells Fargo maintained the shares of BMS in report on Friday, September 8 with “Hold” rating. The rating was maintained by Credit Suisse with “Hold” on Monday, May 1.

Starboard Value Lp, which manages about $2.57B and $4.56 billion US Long portfolio, upped its stake in Ishares Tr (Put) (IWM) by 986,900 shares to 3.95 million shares, valued at $13.19M in 2018Q1, according to the filing. It also increased its holding in Macerich Co (NYSE:MAC) by 1.82M shares in the quarter, for a total of 2.42 million shares, and has risen its stake in Cars Com Inc.

Investors sentiment increased to 0.93 in Q1 2018. Its up 0.04, from 0.89 in 2017Q4. It increased, as 29 investors sold BMS shares while 103 reduced holdings. 34 funds opened positions while 89 raised stakes. 64.30 million shares or 0.60% less from 64.69 million shares in 2017Q4 were reported. Susquehanna Intll Grp Incorporated Llp has invested 0% in Bemis Company, Inc. (NYSE:BMS). Segall Bryant & Hamill Limited Liability Corporation reported 0.71% in Bemis Company, Inc. (NYSE:BMS). Moreover, Raymond James Financial Service Advsrs has 0% invested in Bemis Company, Inc. (NYSE:BMS). 5,232 were accumulated by Ls Advsrs Ltd Liability Corporation. Moreover, Starboard Value Ltd Partnership has 1.9% invested in Bemis Company, Inc. (NYSE:BMS) for 1.99M shares. Plante Moran Advisors Lc reported 343 shares. Moreover, Earnest Partners Limited Liability Co has 0% invested in Bemis Company, Inc. (NYSE:BMS) for 55 shares. Moreover, California Pub Employees Retirement Systems has 0.02% invested in Bemis Company, Inc. (NYSE:BMS). Adage Capital Prtnrs Grp Ltd invested in 291,070 shares. Kings Point Capital invested in 3,031 shares. Thrivent For Lutherans reported 0% stake. 4,986 are held by Jane Street Gru Lc. Mutual Of America Cap Mngmt Limited Liability Co has invested 0.05% in Bemis Company, Inc. (NYSE:BMS). Peninsula Asset Mgmt accumulated 46,920 shares. Evergreen Mngmt Limited Liability Corporation holds 0.18% or 42,650 shares.

Analysts await Bemis Company, Inc. (NYSE:BMS) to report earnings on July, 26. They expect $0.64 earnings per share, up 33.33% or $0.16 from last year’s $0.48 per share. BMS’s profit will be $58.23 million for 16.77 P/E if the $0.64 EPS becomes a reality. After $0.63 actual earnings per share reported by Bemis Company, Inc. for the previous quarter, Wall Street now forecasts 1.59% EPS growth.

Among 33 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 25 have Buy rating, 0 Sell and 8 Hold. Therefore 76% are positive. Biogen Idec Inc. had 133 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has “Hold” rating by Jefferies given on Tuesday, July 11. The company was maintained on Wednesday, October 25 by H.C. Wainwright. Piper Jaffray upgraded the stock to “Overweight” rating in Thursday, November 5 report. The stock of Biogen Inc. (NASDAQ:BIIB) has “Hold” rating given on Thursday, January 25 by Robert W. Baird. Robert W. Baird maintained Biogen Inc. (NASDAQ:BIIB) on Friday, March 11 with “Neutral” rating. On Wednesday, May 2 the stock rating was maintained by Citigroup with “Neutral”. The stock of Biogen Inc. (NASDAQ:BIIB) has “Strong Buy” rating given on Thursday, December 29 by Raymond James. On Monday, October 23 the stock rating was downgraded by Citigroup to “Neutral”. As per Wednesday, August 30, the company rating was maintained by Jefferies. The rating was upgraded by Leerink Swann to “Outperform” on Monday, November 7.

Since January 9, 2018, it had 1 buying transaction, and 5 sales for $10.09 million activity. $75,325 worth of stock was sold by Sandrock Alfred on Tuesday, February 27. 48,000 shares were bought by DENNER ALEXANDER J, worth $12.96M on Wednesday, April 25.

Analysts await Biogen Inc. (NASDAQ:BIIB) to report earnings on July, 24. They expect $5.22 earnings per share, up 3.57% or $0.18 from last year’s $5.04 per share. BIIB’s profit will be $1.10B for 14.64 P/E if the $5.22 EPS becomes a reality. After $6.05 actual earnings per share reported by Biogen Inc. for the previous quarter, Wall Street now forecasts -13.72% negative EPS growth.

Investors sentiment decreased to 1.07 in Q1 2018. Its down 0.10, from 1.17 in 2017Q4. It is negative, as 69 investors sold BIIB shares while 305 reduced holdings. 92 funds opened positions while 308 raised stakes. 178.22 million shares or 1.35% less from 180.65 million shares in 2017Q4 were reported. 12,557 are held by Clough L P. Deutsche Bancshares Ag invested 0.42% in Biogen Inc. (NASDAQ:BIIB). Caprock Group Inc holds 3,073 shares or 0.18% of its portfolio. Qs Investors has invested 0.11% in Biogen Inc. (NASDAQ:BIIB). 5.07M are owned by Wellington Mngmt Group Limited Liability Partnership. Sector Pension Inv Board has 0.03% invested in Biogen Inc. (NASDAQ:BIIB). Reynders Mcveigh Cap Mgmt Lc stated it has 0% of its portfolio in Biogen Inc. (NASDAQ:BIIB). Moreover, Lsv Asset has 0.24% invested in Biogen Inc. (NASDAQ:BIIB) for 562,659 shares. Rathbone Brothers Public Limited Com owns 863 shares. Palisades Hudson Asset Management LP stated it has 1,781 shares. 7,671 are owned by Acg Wealth. 615,005 were accumulated by Dimensional Fund Advsr Limited Partnership. 2,890 were reported by Plancorp Ltd Company. 3,267 are owned by Victory Cap Incorporated. Prentiss Smith Inc invested in 385 shares or 0.06% of the stock.

Bemis Company, Inc. (NYSE:BMS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *